Join the club.

The game is rigged.

Corporate insiders and members of Congress profit every day on information that isn't in the news. We pull back the curtain for you to even the odds. Built for the curious and brave.

Sign up

Coming to iPhone

Soon it trades for you.

This site tells you what an insider bought. The iPhone app closes the loop: it scores every filing the minute it lands, pushes you the handful worth acting on, and places the trade in your own brokerage once you tap approve.

2 min
from a Form 4 hitting EDGAR to a ping on your phone.
1 tap
to approve. Nothing moves without you saying yes.
Your broker
Webull, Robinhood, Schwab or Fidelity. We never hold your money.
Join the waitlist

2,417 already in line

9:41LIVE

THE WALL

Insiders are buying
right now.

319buys filed this month$1.73Bbought
  • Scribe TherapeuticsBehzad Aghazadeh · 10%$36.3Mnow
  • MapLight TherapeuticsCatalyst4, Inc. · 10%$15.3Mtoday
  • Scribe TherapeuticsOrbiMed Advisors · Dir$15.0Mtoday
  • 51Talk OnlineJack Jiajia Huang · CEO$10.7M1d ago
  • Scribe TherapeuticsAH Bio Fund II · 10%$5.0M1d ago
  • Catalyst AcquisitionCatalyst Sponsor · 10%$2.7M2d ago
  • NextCure, Inc.ADAR1 Capital · 10%$1.6M3d ago

+312 more filed in the last 30 days

SC$SCTXScribe Therapeutics0.0%

Behzad Aghazadeh · 10% owner · filed 2 min ago

INSIDER BOUGHT $36.3M3 WEEKS LATER

SCORED VS 350,000 FILINGSWORTH COPYING

  • Size$36.3M
  • Buyers3 this wk
  • Role10% owner

UltraTrader bought it for you

$1,000 of SCTX at $8.42 · your brokerage

Sold, target hit+$0

UULTRATRADER · NOW

Insider buy: $36.3M of SCTX

Behzad Aghazadeh, 10% owner. Copying your $1,000.

Illustration of the flow. The filing is real; the return shown is an example, not a promise.

Inside the club

Here's how insiders are winning.

Real trades from the last month. Every one filed publicly. Every one ignored by almost everyone.

RA CAPITAL MANAGEMENT, L.P.
$COAG
Hemab Therapeutics Holdings, Inc.
+68.6%
RA CAPITAL MANAGEMENT, L.P. · 10% Owner · bought June 17, 2026
RA CAPITAL MANAGEMENT, L.P. made $1.2M
$COAG · daily closepost-filing window

On June 17, 2026, RA CAPITAL MANAGEMENT, L.P, a major shareholder in Hemab Therapeutics Holdings, bought more shares. 30 days later, the stock was up 69%.

If you copied this trade on the filing date and sold 30 days later, you'd be up 69%.
$ACOG
Alpha Cognition Inc.
+40.4%
Opaleye Management Inc. · 10% Owner · bought June 9, 2026
Opaleye Management made $24K
$ACOG · daily closepost-filing window

On June 9, 2026, Opaleye Management Inc, a major shareholder in Alpha Cognition, bought more shares. 30 days later, the stock was up 40%.

If you copied this trade on the filing date and sold 30 days later, you'd be up 40%.
Coastlands Capital LP
$ADIL
ADIAL PHARMACEUTICALS, INC.
+37.4%
Coastlands Capital LP · 10% Owner · bought July 13, 2026
Coastlands Capital made $12K
$ADIL · daily closepost-filing window

On July 13, 2026, Coastlands Capital LP, a major shareholder in ADIAL PHARMACEUTICALS, bought more shares. 20 days later, the stock was up 37%.

If you copied this trade on the filing date and sold 20 days later, you'd be up 37%.

Live data, not a marketing demo

What insiders did this week.

Every row is a real SEC filing. Tap anything to see the full story. That part's behind a subscription.

Corporate insiders

Latest big buys

See all corporate trades
Congress trades

Senators & Reps

Browse all Congress trades
Market news

Daily briefs

Read more news

What we actually do

We're not a Form 4 viewer.

Plenty of free sites already show you every filing. We do the next step: tell you which ones actually move stocks.

The raw stuff

SEC EDGAR & OpenInsider

  • Every Form 4, in the order it landed
  • Tables of tickers, dates, dollar amounts
  • Free. Anyone can read them

The signal

InsiderSignal.ai

  • Only the filings that match patterns we've seen win
  • AI analysis on every trade, in plain English
  • Built on 350,000+ insider trades we've studied
Get started

Pick a plan

Get a piece of the action.

Two tiers. Cancel any time. Sign up takes about 60 seconds.

Plus
For the curious investor
$15.83/month
$190 billed yearly
  • Full access to every insider trade
  • Filter, search, and watchlists
  • Plain-English AI analysis on every trade
  • Daily market news, fully unlocked
  • Track up to 20 stocks
Recommended
Pro
For the serious trader
$165.83/month
$1,990 billed yearly
  • Everything in Plus
  • Real-time alerts the moment validated patterns fire
  • 10× more AI insights: research chat, trade analysis, no daily caps
  • API access for trading bots and custom integrations
  • Unlimited watchlist

Common questions.

Where does the data come from?

Corporate insider trades come directly from SEC Form 4 filings. Congress trades come from STOCK Act disclosures. All of it is public. We monitor it, score it, and tell you which ones matter.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Insider trading on private information is illegal, but that's a different thing.

What's the difference between you and OpenInsider?

OpenInsider gives you raw filing data: every Form 4 in the order it landed. We've analyzed 350,000+ insider trades to find which patterns actually predicted price moves, and we surface the ones that match those patterns in real time.

Can I cancel?

Any time, from your account page. No phone call. No retention chat. You keep access until the end of the billing period you already paid for.

What we show is real and public. What you do with it is your call. Not financial advice.

Latest Insider Purchases